284 related articles for article (PubMed ID: 23320773)
21. Survival analysis of head and neck squamous cell carcinoma: influence of smoking and drinking.
Farshadpour F; Kranenborg H; Calkoen EV; Hordijk GJ; Koole R; Slootweg PJ; Terhaard CH
Head Neck; 2011 Jun; 33(6):817-23. PubMed ID: 20737489
[TBL] [Abstract][Full Text] [Related]
22. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
23. The impact of comorbidities on survival in oral cancer patients: a population-based, case-control study.
Ghanizada M; Jakobsen KK; Jensen JS; Wessel I; Filtenborg Tvedskov J; Grønhøj C; von Buchwald C
Acta Oncol; 2021 Feb; 60(2):173-179. PubMed ID: 33103528
[TBL] [Abstract][Full Text] [Related]
24. Impact of comorbidity on treatment outcome in head and neck squamous cell carcinoma - a systematic review.
Bøje CR
Radiother Oncol; 2014 Jan; 110(1):81-90. PubMed ID: 23953753
[TBL] [Abstract][Full Text] [Related]
25. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
[TBL] [Abstract][Full Text] [Related]
26. Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.
Ju J; Wang J; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Sun M
Oncotarget; 2016 Aug; 7(32):51059-51068. PubMed ID: 27419636
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):85-92. PubMed ID: 30252608
[TBL] [Abstract][Full Text] [Related]
28. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
29. Trends in all-cause five-year mortality after head and neck cancers diagnosed over a period of 33 years. Focus on estimated degree of association with human papillomavirus.
Svahn MF; Munk C; Nielsen TS; von Buchwald C; Frederiksen K; Kjaer SK
Acta Oncol; 2016; 55(9-10):1084-1090. PubMed ID: 27550781
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.
Birkeland AC; Rosko AJ; Chinn SB; Prince ME; Sun GH; Spector ME
ORL J Otorhinolaryngol Relat Spec; 2016; 78(2):61-9. PubMed ID: 26910465
[TBL] [Abstract][Full Text] [Related]
31. Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008.
Land LH; Dalton SO; Jensen MB; Ewertz M
Breast Cancer Res Treat; 2012 Feb; 131(3):1013-20. PubMed ID: 22002567
[TBL] [Abstract][Full Text] [Related]
32. Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy?
Bonomo P; Desideri I; Loi M; Lo Russo M; Olmetto E; Maragna V; Francolini G; Delli Paoli C; Grassi R; Pezzulla D; Greto D; Meattini I; Livi L
Oral Oncol; 2017 Nov; 74():142-147. PubMed ID: 29103743
[TBL] [Abstract][Full Text] [Related]
33. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
34. Impact of Type 2 Diabetes Mellitus on Survival in Head and Neck Squamous Cell Carcinoma.
Foreman A; Lee DJ; McMullen C; de Almeida J; Muhanna N; Gama RR; Giuliani M; Liu G; Bratman SV; Huang SH; O'Sullivan B; Song Y; Xu W; Goldstein DP
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):657-663. PubMed ID: 28849730
[TBL] [Abstract][Full Text] [Related]
35. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
[TBL] [Abstract][Full Text] [Related]
36. The Charlson comorbidity index is a prognostic factor in sinonasal tract squamous cell carcinoma.
Suzuki H; Hanai N; Nishikawa D; Fukuda Y; Koide Y; Kodaira T; Tachibana H; Tomita N; Makita C; Hasegawa Y
Jpn J Clin Oncol; 2016 Jul; 46(7):646-51. PubMed ID: 27162318
[TBL] [Abstract][Full Text] [Related]
37. Role of comorbidity on outcome of head and neck cancer: a population-based study in Thuringia, Germany.
Göllnitz I; Inhestern J; Wendt TG; Buentzel J; Esser D; Böger D; Mueller AH; Piesold JU; Schultze-Mosgau S; Eigendorff E; Schlattmann P; Guntinas-Lichius O
Cancer Med; 2016 Nov; 5(11):3260-3271. PubMed ID: 27726294
[TBL] [Abstract][Full Text] [Related]
38. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
[TBL] [Abstract][Full Text] [Related]
39. Impact of age, comorbidity, and WHO performance status on delay of treatment in patients undergoing fast-track work-up for head and neck cancer.
Carlsen AH; Eriksen JG; Godballe C; Johansen J; Sørensen JA; Bjørndal K
J Geriatr Oncol; 2019 Mar; 10(2):259-264. PubMed ID: 29950282
[TBL] [Abstract][Full Text] [Related]
40. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
